Pfizer Biontech Coronavirus Vaccine
-
{
- All
- News
-
The Pfizer/BioNTech Vaccine Bet That Paid Off
With a strategic alliance, 24-hour production and a bit of luck, Pfizer and BioNTech were able to roll out their Covid vaccine at a brisk pace and relatively free of controversy.
-
US Signs $2 Billion Deal With Pfizer, BioNTech For 100 Million COVID-19 Vaccines
The United States on on Tuesday signed a $1.95 billion agreement with US pharma giant Pfizer and Germany's BioNTech for 100 million doses of their experimental COVID-19 vaccine, part of an aggressive push to start immunizing Americans early next year.
-
The Pfizer/BioNTech Vaccine Bet That Paid Off
With a strategic alliance, 24-hour production and a bit of luck, Pfizer and BioNTech were able to roll out their Covid vaccine at a brisk pace and relatively free of controversy.
-
US Signs $2 Billion Deal With Pfizer, BioNTech For 100 Million COVID-19 Vaccines
The United States on on Tuesday signed a $1.95 billion agreement with US pharma giant Pfizer and Germany's BioNTech for 100 million doses of their experimental COVID-19 vaccine, part of an aggressive push to start immunizing Americans early next year.
